Rapidly progressive moyamoya vasculopathy stabilized with immunotherapy in aicardi-goutières syndrome

Jenae Vancura¹, Natalie K Boyd², Benjamin N Vogel², Deepti Nagesh^{2

3}, Eugenia Ho^{2

3}, Jonathan D Santoro^{4

5

6}

Affiliations

¹ Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
² Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA.
³ Department of Neurology, Keck School of Medicine of the, University of Southern California, Los Angeles, CA, USA.
⁴ Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA. jdsantoro@chla.usc.edu.
⁵ Department of Neurology, Keck School of Medicine of the, University of Southern California, Los Angeles, CA, USA. jdsantoro@chla.usc.edu.
⁶ Division of Neuroimmunology, Children's Hospital Los Angeles, 4650 Sunset Blvd, MS 82, Los Angeles, CA, 90027, USA. jdsantoro@chla.usc.edu.

Jenae Vancura et al. J Neurol. 2024 Feb.

. 2024 Feb;271(2):1019-1022.

doi: 10.1007/s00415-023-12040-2. Epub 2023 Oct 19.

Jenae Vancura¹, Natalie K Boyd², Benjamin N Vogel², Deepti Nagesh^{2

3}, Eugenia Ho^{2

3}, Jonathan D Santoro^{4

5

6}

¹ Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
² Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA.
³ Department of Neurology, Keck School of Medicine of the, University of Southern California, Los Angeles, CA, USA.
⁴ Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, CA, USA. jdsantoro@chla.usc.edu.
⁵ Department of Neurology, Keck School of Medicine of the, University of Southern California, Los Angeles, CA, USA. jdsantoro@chla.usc.edu.
⁶ Division of Neuroimmunology, Children's Hospital Los Angeles, 4650 Sunset Blvd, MS 82, Los Angeles, CA, 90027, USA. jdsantoro@chla.usc.edu.

No abstract available

References

1. Rice GI, Bond J, Asipu A et al (2009) Mutations involved in aicardi-goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41:829–832. https://doi.org/10.1038/ng.373 - DOI - PubMed - PMC
1. Crow YJ (2005) Aicardi-goutières syndrome. In: Adam MP, Mirzaa GM, Pagon RA (eds) GeneReviews®. University of Washington, Seattle, Seattle (WA)
1. Crow YJ, Vanderver A, Orcesi S, Kuijpers TW, Rice GI (2014) Therapies in aicardi-goutières syndrome. Clin Exp Immunol 175(1):1–8. https://doi.org/10.1111/cei.12115 - DOI - PubMed
1. Crow YJ, Manel N (2015) Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol 15(7):429–440. https://doi.org/10.1038/nri3850 - DOI - PubMed
1. Garau J, Cavallera V, Valente M et al (2019) Molecular genetics and interferon signature in the italian aicardi goutières syndrome cohort: report of 12 new cases and literature review. J Clin Med 8(5):750. https://doi.org/10.3390/jcm8050750 - DOI - PubMed - PMC